U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low 
What’s the difference between baking powder and baking soda? It’s subtle, but significant 
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back 
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey 
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge 
Disaster or digital spectacle? The dangers of using floods to create social media content 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
